Insulin resistance and non-insulin-dependent diabetes mellitus: Cellular and molecular mechanisms

American Journal of Clinical Nutrition

Volumn 61, Issue 4 SUPPL., 1995, Pages

  Olefsky, Jerrold M ^a   Nolan, John J ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NONE

Author keywords

autophosphorylation; hepatic glucose production; hyperglycemia; insulin receptor; insulin resistance; Non insulin dependent diabetes mellitus; phosphorylation cascade; polygenic inheritance

Indexed keywords

ANTIDIABETIC AGENT; DISULFIDE; GLUCAGON; GLUCOSE; GLUCOSE TRANSPORTER; INSULIN; INSULIN RECEPTOR; PROTEIN TYROSINE KINASE;

ADIPOCYTE; AUTOPHOSPHORYLATION; CONFERENCE PAPER; GENE; GLUCONEOGENESIS; GLUCOSE UTILIZATION; HUMAN; HYPERGLYCEMIA; HYPERINSULINEMIA; INSULIN RELEASE; INSULIN RESISTANCE; LIVER; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; PANCREAS ISLET BETA CELL; SKELETAL MUSCLE;

EID: 0028918346     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcn/61.4.980S     Document Type: Conference Paper

References (52)

1. Olefsky JM. Pathogenesis of non-insulin dependent diabetes (Type II). In: DeGroot LJ, Besser GM, Cahill JC, eds. Endocrinology. 2nd ed. Philadelphia: WB Saunders Co, 1989:1369-88.
2. DeFronzo RA. The triumvirate: β-cell, muscle, liver: a collusion responsible for NIDDM. Diabetes 1988;37:667-87.
3. Reaven GM. Role of insulin resistance in human disease. Diabetes 1988;37:1595-607.
4. Efendic S, Luft R, Wajngot A. Aspects of the pathogenesis of Type 2 diabetes. Endocr Rev 1984;5:395-410.
5. Rotter JL, Vadheim CM, Rimoin DL. Genetics of diabetes mellitus. In: Rifkin H, Porte D Jr, eds. Diabetes mellitus: theory and practice. New York: Elsevier, 1990:378-413.
6. Olefsky JM. Insulin action and insulin resistance in non-insulin dependent diabetes mellitus. In: Shigeta Y, Kobayashi M, Olefsky JM. Recent advances in insulin action and its disorders. Amsterdam: Excerpta Medica, 1991:81-118.
7. Caro JF, Dohm GL, Pories WJ, Sinha MK. Cellular alterations in liver, skeletal muscle, and adipose tissue responsible for insulin resistance in obesity and Type II diabetes. Diabetes Metab Rev 1989;5:665-89.
8. Olefsky JM. Diabetes mellitus. In: Wyngaarden JB, Smith LH Jr, Bennett JC, Plum F, eds. Cecil's textbook of medicine. 18th ed. Vol 2. Philadelphia: WB Saunders, 1991:1360-81.
9. Kolterman OG, Gray RS, Griffin J, et al. Receptor and post-receptor defects contribute to the insulin resistance in non-insulin dependent diabetes mellitus. J Clin Invest 1981;68:957-69.
10. Reaves RR, Fink R, Griffin J, Olefsky JM, Kolterman OG. Influence of hyperglycemia on insulin's in vivo effects of Type II diabetes. J Clin Invest 1984;73:664-72.
11. Bogardus C, Lillioja S, Howard BV, Reaven G, Mott D. Relationships between insulin secretion, insulin action, and fasting plasma glucose concentration in non-diabetic and non-insulin-dependent diabetic subjects. J Clin Invest 1984;74:1238-46.
12. Dinneen S, Gerich J, Rizza R. Carbohydrate metabolism in non-insulin-dependent diabetes mellitus. N Engl J Med 1992;327:707-13.
13. Caro JF. Clinical review 26: insulin resistance in obese and nonobese man. J Clin Endocrinol Metab 1991;73:691-5.
14. Hother-Nielsen O, Schmitz O, Andersen PH, Beck-Nielsen H, Pedersen O. Metformin improves peripheral but not hepatic insulin action in obese patients with type I diabetes. Acta Endocrinol (Copenh) 1989;120:257-65.
15. Bonadonna RC, DeFronzo RA. Glucose metabolism in obesity and Type 2 diabetes. Diabetes Metab (Paris) 1991;17:112-35.
16. Reaven GM. Resistance to insulin-stimulated glucose uptake and hyperinsulinemia: role in non-insulin-dependent diabetes mellitus, high blood pressure, dyslipidemia and coronary heart disease. Diabetes Metab (Paris) 1991;17:78-86.
17. Bogardus C, Lillioja S, Howard BV, Reaven G, Mott D. Relationships between insulin secretion, insulin actin, and fasting plasma glucose concentration in non-diabetic and non-insulin-dependent diabetic subjects. J Clin Invest 1984;74:1238-46.
18. Ward WK, Beard JC, Halter JB, Pfeifer MA, Porte D Jr. Pathophysiology of insulin secretion in non-insulin-dependent diabetes mellitus. Diabetes Care 1984;7:491-502.
19. Garvey WT, Olefsky JM, Griffin J, Hammon R, Kolterman OG. The effects of insulin treatment on insulin secretion and action in Type II diabetes mellitus. Diabetes 1985;34:222-34.
20. Henry RR, Wallace P, Olefsky JM. The effects of weight loss on the mechanisms of hyperglycemia in obese noninsulin-dependent diabetes mellitus. Diabetes 1986;35:990-8.
21. Kolterman OG, Gray RS, Shapiro G, Scarlett JA, Griffin J, Olefsky JM. The acute and chronic effects of sulfonylurea therapy in Type II diabetes. Diabetes 1984;33:346-54.
22. Suter SL, Nolan JJ, Wallace P, Gumbiner B, Olefsky JM. Metabolic effects of new oral hypoglycemic agent CS-045 in NIDDM subjects. Diabetes Care 1992;15:193-203.
23. DeFronzo RA, Ferrannini E. The pathogenesis of non-insulin-dependent diabetes. Medicine 1982;61:125-40.
24. Reaven GM, Olefsky JM. Relationship between heterogeneity of insulin responses and insulin resistance in normal subjects. Diabetologia 1977;13:201-6.
25. Henry RR, Scheaffer L, Olefsky JM. Glycemic effects of short-term intensive dietary restriction and isocaloric refeeding in non-insulin dependent diabetes mellitus. J Clin Endocrinol Metab 1985;61:917-25.
26. DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 1979;237:E214-23.
27. Eriksson J, Franssila-Kallunki A, Ekstrand A, et al. Early metabolic defects in persons at increased risk for non-insulin dependent diabetes mellitus. N Engl J Med 1989;321:337-43.
28. Vaag A, Henriksen JE, Handberg A, Beck-Nielsen H. Localizing inherited defects of glucose metabolism in NIDDM (non-insulin dependent diabetes mellitus). V. International Symposium on Insulin Receptor and Insulin Action. Molecular and clinical aspects. Exp Clin Endocrinol 1993;101(suppl 2):295(abstr).
29. Muller HK, Kellerer M, Ermel B, et al. Prevention by protein kinase C inhibitors of glucose-induced insulin receptor tyrosine kinase resistance in rat fat cells. Diabetes 1991;40:1440-8.
30. Mosthaf L, Berti L, Kroder G, et al. Glucose induced translocation of protein kinase C isoforms in rat-1 fibroblasts is paralleled by inhibition of the insulin receptor tyrosine kinase. Exp Clin Endocrinol 1993; 101(suppl 2):150-1.
31. Rosen OM. After insulin binds. Science 1987;237:1452-8.
32. Kahn CR, White MF. The insulin receptor and the molecular mechanism of insulin action. J Clin Invest 1988;82:1151-6.
33. Olefsky JM. The insulin receptor: a multi-functional protein. Diabetes 1990;39:1009-16.
34. Haring HU. The insulin receptor: signaling mechanism and contribution to the pathogenesis of insulin resistance. Diabetologia 1991;34:848-61.
35. Kasuga M, Karlsson FA, Kahn CR. Insulin stimulates the phosphorylation of the 95,000 Dalton subunit of its own receptor. Science 1982;215:185-7.
36. Tornqvist HE, Pierce MW, Frackelton AR. Identification of insulin receptor tyrosine residues autophosphorylated in vitro. J Biol Chem 1987;262:10212-9.
37. White MF, Shoelson SE, Keutmann H, Kahn CR. A cascade of tyrosine autophosphorylation in the β-subunit activates the insulin receptor. J Biol Chem 1988;263:2969-80.
38. Fink RI, Wallace P, Brechtel G, Olefsky JM. Evidence that glucose transport is rate-limiting for in vivo glucose uptake. Metabolism 1992; 41:897-902.
39. Idstrom J-P, Rennie MJ, Schersten T, Bylund-Fellenius AC. Membrane transport in relation to net uptake of glucose in the perfused rat hindlimb. Biochem J 1986;233:131-7.
40. Kubo K, Foley JE. Rate-limiting steps for insulin-mediated glucose uptake into perfused rat hindlimb. Am J Physiol 1986;250:E100-2.
41. Pessin JE, Bell GI. Mammalian facilitative glucose transport family: structure and molecular regulation. Annu Rev Physiol 1992;54:911-30.
42. Mueckler M. Family of glucose transporter genes. Diabetes 1990;39: 6-11.
43. Cushman SW, Wardzala LJ. Potential mechanism of insulin action on glucose transport in the isolated rat adipose cell. J Biol Chem 1980; 255:4758-62.
44. Kono T, Suzuki K, Dansey LE, Robinson FW, Blewis TL. Energy-dependent and protein synthesis-independent recycling of the insulin-sensitive glucose transport mechanism in fat cells. J Biol Chem 1981; 256:6400-7.
45. Freidenberg GR, Henry RR, Klein HH, Reichart DR, Olefsky JM. Decreased kinase activity of insulin receptors from adipocytes of non-insulin dependent diabetic (NIDDM) subjects. J Clin Invest 1987;79:240-50.
46. Caro JF, Ittop O, Pories WJ, et al. Studies on the mechanism of insulin resistance in the liver from humans with non-insulin-dependent diabetes. J Clin Invest 1986;78:249-58.
47. Caro JF, Sinha MK, Raju SJ, et al. Insulin receptor kinase in human skeletal muscle from obese subjects with and without non-insulin-dependent diabetes. J Clin Invest 1987;79:1330-7.
48. Arner P, Pollare T, Uthell H, Livingston JN. Defective insulin receptor tyrosine kinase in human skeletal muscle in obesity and Type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 1987;30:437-40.
49. Comi RJ, Grunberger G, Gorden P. The relationship of insulin binding and insulin-stimulated tyrosine kinase activity is altered in Type II diabetes. J Clin Invest 1987;79:453-62.
50. Maegawa H, Shigeta Y, Egawa K, Kobayashi M. Impaired autophosphorylation of insulin receptors from abdominal skeletal muscles in nonobese subjects with NIDDM. Diabetes 1991;40:815-9.
51. Nolan JJ, Freidenberg G, Henry R, Reichart D, Olefsky JM. Role of human skeletal muscle insulin receptor kinase in the in vivo insulin resistance of non-insulin dependent diabetes mellitus and obesity. J Clin Endocrinol Metab 1994;78:471-7.
52. Freidenberg GR, Reichart D, Olefsky JM, Henry RR. Reversibility of defective adipocyte insulin receptor kinase activity in non-insulin dependent diabetes mellitus: effects of weight loss. J Clin Invest 1988;82:1398-406.